Health Canada Announces Rules for Cannabis Packaging Ahead of 2018 Legalization | CashCropToday
0 Shares 185 Views

Health Canada Announces Rules for Cannabis Packaging Ahead of 2018 Legalization

March 20, 2018
185 Views

The Canadian government has released rules regarding the packaging and branding of recreational cannabis products throughout the country. This news comes months away from the proposed legalization of cannabis country wide.

Regulations are made stringent in an attempt to keep cannabis products away from youth. Some regulations include the standardization of the type of color manufacturers can use on your packaging and restricts the way that they can brand their products. The Canadian government will also require a mandatory warning label.

Most importantly, a universal symbol will be implemented which will warn consumers that their is THC within said product.

“What we’ve heard from Canadians is clear: these regulations must protect the health and safety of Canadians, particularly our youth, while at the same time enabling a diverse, competitive and legal industry comprising both large and small players that can displace the existing illicit market for cannabis. Its very important for us to ensure the safety features are there in place,” Health Minister Ginette Petitpas Taylor told reporters Monday. “We want to make sure that it’s child-proof and that it’s tamper-evident.”

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
188 views
Global
188 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
186 views
Manufacturing
186 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: